CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion SVP & GENERAL COUNSEL acquired 4,101 shares (option exercise)
- 4 Other disposition SVP & GENERAL COUNSEL disposed of 39,709 shares (other)
- 4 Open-market sale 10% owner sold 140,000 shares at $7.56 ($1,058,400)
- 4 Open-market sale Director sold 140,000 shares at $7.56 ($1,058,400)
- 4 Open-market sale Director sold 210,809 shares at an average $7.38 ($1,554,954)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 7,394 shares (option exercise)
- 4 Open-market sale Director sold 205,800 shares at an average $4.22 ($867,734)
Page 15 of 23 · 459 filings